GO
Loading...

Squawk Box

More

  • My Herbalife short is looking much better: Ackman Wednesday, 23 Apr 2014 | 12:09 PM ET
    An employee carries a box of products for shipment to a truck at the Herbalife Los Angeles distribution center in Carson, Calif.

    Bill Ackman tells CNBC that his losses from betting against Herbalife have been "more than cut in half" based on the recent downturn of the company's stock.

  • I did not front-run Allergan stock, Ackman says Wednesday, 23 Apr 2014 | 9:40 AM ET
    Bill Ackman

    Bill Ackman also tells CNBC that Allergan's poison-pill defense doesn't make his takeover bid more difficult.

  • Too many Dunkin' Donuts?     Wednesday, 23 Apr 2014 | 8:55 AM ET

    Dunkin' Brands plans to have 1,000 stores in the Golden State, reports CNBC's Jane Wells with a look at the company's expansion plans.

  • Cramer: It wasn't front running     Wednesday, 23 Apr 2014 | 8:45 AM ET

    CNBC's Jim Cramer shares his thoughts on the legality of Bill Ackman's deal with Valeant to acquire Allergan, and why the SEC has an "existential crisis."

  • Will shareholders KO compensation plan?     Wednesday, 23 Apr 2014 | 8:32 AM ET

    Jason Subotky, Yacktman Funds, shares his thoughts on Coca-Cola's equity compensation plan. The problem with these plans are they are complicated and a lot of the details are not fully flushed out, says Subotky.

  • Facebook is our top pick for 2014: Analyst     Wednesday, 23 Apr 2014 | 8:12 AM ET

    Anthony DiClemente, Nomura senior analyst, shares his upbeat outlook on the social media giant, as advertising dollars continue to shift towards digital media.

  • AT&T transforming customer base: CFO     Wednesday, 23 Apr 2014 | 8:04 AM ET

    John Stephens, AT&T CFO, delves into Ma Bell's quarterly numbers and weighs in on the company's strategy to increase its wireless subscribers.

  • William Ackman, Pershing Square Capital Management, explains how his partnership with Valeant is structured. And J. Michael Pearson, Valeant chairman & CEO, discusses why he partnered with Ackman instead of pursing Allergan alone. Creating shareholder value is our job, says Pearson.

  • Ackman: Allergan clear fit for Valeant     Wednesday, 23 Apr 2014 | 7:41 AM ET

    William Ackman, Pershing Square Capital Management, explains why he is helping Valeant buy Allergan.

  • J. Michael Pearson, Valeant Pharmaceuticals chairman & CEO, weighs in on news that Allergan has adopted a "poison pill" defense strategy. Also Pearson shares his thoughts on adding some of Allergan's notable cosmetic products like Botox and Restasis to its growing arsenal.

  • Valeant CEO: Allergan has a great set of assets     Wednesday, 23 Apr 2014 | 7:33 AM ET

    J. Michael Pearson, Valeant Pharmaceuticals chairman & CEO, explains why he decided to pursue Allergan and shares his R&D business model, with CNBC's Kate Kelly. This year we are launching 19 products in the United States, says Pearson.

  • Ackman: Valeant fit into Pershing investing mold     Wednesday, 23 Apr 2014 | 7:32 AM ET

    William Ackman, Pershing Square Capital Management, explains why he decided to team up with Valeant Pharmaceuticals to make a play for Allergan.

  • Boeing Q1 beats on top and bottom line     Wednesday, 23 Apr 2014 | 7:30 AM ET

    Boeing's profit margin on the commercial side improves to 11.8 percent, reports CNBC's Phil LeBeau with a break down on Boeing's quarterly results.

  • P&G Q3 profit rises     Wednesday, 23 Apr 2014 | 7:17 AM ET

    Jon Moeller, Procter & Gamble CFO, breaks down the company's third quarter results of $1.04 EPS ex-items on revenues of $20.56 billion and weighs in on where the company sees global growth.

  • Dow CEO: We engage activist investors     Wednesday, 23 Apr 2014 | 7:11 AM ET

    Most of these investors are looking for a dialogue to improve value, says Andrew Liveris, President, Chairman & CEO of Dow Chemical, sharing his thoughts on activist investors.

  • Dow Chemical reports Q1 earnings beat     Wednesday, 23 Apr 2014 | 7:03 AM ET

    We overcame transport and weather issues in North American, says Andrew Liveris, President, Chairman & CEO of Dow Chemical, breaking down his company's first quarter results of $0.79 EPS on revenues of $14.46 billion.

  • Yummie: Not your grandma's girdle anymore     Wednesday, 23 Apr 2014 | 6:50 AM ET

    It's not a dirty little secret anymore, says Heather Thomson, Yummie by Heather Thomson founder, discussing how her company is redefining the shapewear industry and carving out a piece of the market.

  • Don't look at tech as one big blob: Pro     Wednesday, 23 Apr 2014 | 6:33 AM ET

    Investors need to separate new tech from old tech, says Christopher Wolfe, Merrill Lynch, sharing his views on whether there's a tech bubble brewing. And Mark Haefele, UBS Wealth Management, weighs in.

  • iPhone 6 will reward Apple: Analyst     Wednesday, 23 Apr 2014 | 6:13 AM ET

    Chris Caso, Susquehanna Financial Group analyst, shares his outlook on Apple in the second half. Apple needs to show shareholders the next new thing, says Caso.

  • Pharma deal frenzy     Tuesday, 22 Apr 2014 | 10:01 AM ET

    CNBC's Meg Tirrell digs into the friendly and hostile M&A action taking place in pharmaceuticals, including a deal between Novartis and GlaxoSmithKline, and Valeant Pharmaceuticals bid for Allergan.

About Squawk Box

  • "Squawk Box" is the ultimate "pre-market" morning news and talk program, where the biggest names in business and politics tell their most important stories. Anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin, the show brings Wall Street to Main Street. It's a "must see" for everyone from the professional trader to the casual investor.

Contact Squawk Box

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More
  • Showtimes

    U.S.
    Weekdays 6a ET
    EMEA
    Weekdays 13:00 CET
    Asia
    Weekdays 18:00 SIN/HK
    Australia
    Weekdays 20:00 SYD
    New Zealand
    Weekdays 22:00 NZ

 

  • Joe Kernen is co-anchor of "Squawk Box," CNBC's signature morning program.

  • Becky Quick is co-anchor of "Squawk Box," CNBC's signature morning program. She's also a columnist for Fortune.

  • Andrew Ross Sorkin is a co-anchor of "Squawk Box," a financial columnist for "The New York Times" and the editor-at-large of NYT's DealBook.

Most Popular Video

Thursday, 24 Apr 2014 | 1:05 AM ET

Jerry Braakman, chief investment officer at First American Trust, says Apple and Facebook reported "great" results and owning technology stocks is still attractive.

Thursday, 24 Apr 2014 | 12:16 AM ET

Manpreet Gill, Senior Investment Strategist at Standard Chartered Bank, attributes the decline of Japanese shares to the lack of a TPP agreement during U.S. President Barack Obama's visit to Tokyo.

Wednesday, 23 Apr 2014 | 3:00 PM ET

CNBC's Becky Quick discusses Warren Buffett's feelings about Coke, IBM and his general sentiment about the market.